| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 苔黑酚葡萄糖苷; Sakakin | CFN98059 | 21082-33-7 | C13H18O7 = 286.3 | 20mg | QQ客服：2159513211 |
| Rubranol; Rubranol | CFN98060 | 211126-61-3 | C19H24O5 = 332.4 | 5mg | QQ客服：2159513211 |
| 2,3,5,4-四羟基二苯乙烯葡萄糖苷; 2,3,5,4'-Tetrahydroxyl diphenylethylene-2-O-glucoside | CFN99995 | 82373-94-2 | C20H22O9 = 406.39 | 20mg | QQ客服：1457312923 |
| 银松素; Pinosylvin | CFN98203 | 22139-77-1 | C14H12O2 = 212.3 | 20mg | QQ客服：215959384 |
| 3,3'-O-二甲基鞣花酸; 3,8-Di-O-methylellagic acid | CFN98217 | 2239-88-5 | C16H10O8 = 330.3 | 5mg | QQ客服：1457312923 |
| 决明柯酮; Torachrysone | CFN98224 | 22649-04-3 | C14H14O4 = 246.3 | 5mg | QQ客服：1413575084 |
| 石榴皮鞣素; Punicalin | CFN98113 | 65995-64-4 | C34H22O22 = 782.52 | 20mg | QQ客服：215959384 |
| 3-香叶草基-4-甲氧基苯甲酸; 3-Geranyl-4-methoxybenzoic acid | CFN98266 | 246266-38-6 | C18H24O3 = 288.4 | 5mg | QQ客服：215959384 |
| 大麻萜酚; Cannabigerol | CFN98287 | 25654-31-3 | C21H32O2 = 316.5 | 10mg | QQ客服：2159513211 |
| 3,4,5-三甲氧基苯酚芦丁糖甙; Antiarol rutinoside | CFN98298 | 261351-23-9 | C21H32O13 = 492.5 | 5mg | QQ客服：2056216494 |
| 柳匍匐次苷; Salirepin | CFN98314 | 26652-12-0 | C13H18O8 = 302.3 | 5mg | QQ客服：2056216494 |
| 6-羟基苯并呋喃-2(3H)-酮; 6-Hydroxybenzofuran-2(3H)-one | CFN98320 | 2688-49-5 | C8H6O3 = 150.1 | 5mg | QQ客服：2056216494 |
| 根皮酚-beta-D-葡糖甙; Phlorin | CFN98343 | 28217-60-9 | C12H16O8 = 288.3 | 5mg | QQ客服：2159513211 |
| 仙鹤草酚B; Agrimol B | CFN98169 | 55576-66-4 | C37H46O12 = 682.75 | 20mg | QQ客服：1457312923 |
| 3,4-二羟基苯基二醇; 3,4-Dihydroxyphenylglycol | CFN98355 | 28822-73-3 | C8H10O4 = 170.2 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)